The aim of our project is to explore in deep the role of the cIrcular RNA in the Multiple Sclerosis etiopathogenic. To do that, and based in our previous results, we are going to study cirCRNA expression profile in Clinically Isolated Syndromes and in patients at the relapse moment and in the remission phase. However, the implication of CircRNA in Multiple Sclerosis is not just as a biomarker but also playing a function. To clarify these functions we are going to study 1) their role in the regulation of the immune response through the PKR pathway in patients and controls serum and PBMC. 2) Their role as key regulators of the Transcriptional network acting as a sponge of the microRNAS, studying the expression in PBMS from patients and controls of the in silico predicted circRNA-miRNA unions, and 3) studying the possible products from the transcription of some of the differentially expressed circRNA in PBMC and serum from patients and controls. In resume, we propose to study around 200 patients and 20 healthy controls to clarify the role of the circular RNAs in the MS pathology, as potential biomarkers and as molecule implicated in the disease, and therefore potentially druggable.
RNA circular
esclerosis múltiple
biomarcador
PKR
inmunidad innata
regulación transcriptoma
Acción Estratégica en Salud (AES)
01/01/2021 - 31/12/2023
DAVID OTAEGUI BICHOT
ASOCIACION INSTITUTO BIODONOSTIA
INSTITUTO DE INVESTIGACION SANITARIA BIODONOSTIA
PAIS VASCO
GUIPUZCOA
183,920 €